IQInvest
Sign in

DIVISLAB.NS

Divi's Laboratories Limited

NSI · Healthcare

₹8,744.50

₹248.50 (+2.92%)up 2.92%

25 August 2026 · delayed 15+ min

F

Quality score55.1 / 100

Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.

Divi's Laboratories Limited earns a F on excellent profit margins (>20%) and low debt-to-equity ratio but MACD bearish (negative histogram) and high P/E ratio (90.3) - may be overvalued. Consider alternatives with better risk/reward profiles.

Model stance WEAK HOLD Suggested position 4.0% · ₹400.00 IQInvest estimate
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these

These change the suggested position size and the stance, not the category scores. Amount is in rupees.

IQ-DIVISLAB.NS-20260825engine v1 · 7-category weighted scorecard

What it is worth, depending who you ask.

Today’s price against the year it has had and the targets analysts publish. Every marker is a reported figure, not a projection of ours.

52-week low

₹5,636.50

Lowest analyst target

₹6,000.00

Mean analyst target

₹8,292.48

Today's price

₹8,744.50

52-week high

₹8,744.50

Highest analyst target

₹11,700.00

DIVISLAB.NS trades at its 52-week high, between ₹5,636.50 and ₹8,744.50. The mean analyst target of ₹8,292.48 is 5.2% below today's price.

Today’s price 52-week range Analyst price targets

Scored categories

Financial healthExcellent profit margins (>20%); Low debt-to-equity ratio 95.023%

Profit margin

26.05%

Net profit per unit of revenue

exceptionalWhat this means

Of every 100 units of revenue, this much survives as profit.

Margins this wide usually mean real pricing power or a moat.

Operating margin

36.66%

Before interest and tax

very highWhat this means

Profit from operations, before interest and tax, per 100 of revenue.

Typical of software and other businesses with little cost per extra sale.

Gross margin

61.24%

After the cost of goods only

highWhat this means

What is left of revenue after only the direct cost of the product.

Little marginal cost per sale, which is what lets software and pharma fund heavy R&D.

Debt to equity

0.04

Borrowings against equity

conservativeWhat this means

Borrowings measured against shareholder capital.

Comfortably financed.

Revenue growth

27.80%

Year on year

fast-growingWhat this means

Change in revenue against the same period last year.

Rapid growth, though the question is always how long it can hold.

Earnings growth

65.70%

Year on year

very strongWhat this means

Change in earnings against the same period last year.

Check whether it is repeatable or a one-off — a single asset sale can flatter this badly.

Revenue

₹11,230 Cr

Trailing twelve months

Payout ratio

31.01%

Dividends as a share of earnings

conservativeWhat this means

The share of earnings paid out as dividends.

Comfortably covered, with room to keep raising it.

Growth & momentum5 measured figures 55.022%

Sharpe ratio

0.51

Return earned per unit of risk

modestWhat this means

Return earned per unit of risk taken.

Below 1 is the common case; return did not strongly outpace the volatility.

Win rate

50.89%

Share of days that closed up

about evenWhat this means

The share of trading days that closed higher.

Close to a coin flip, which is the norm — returns come from the size of moves, not their count.

Average daily return

0.06%

Best day

9.73%

Worst day

-11.71%

ValuationHigh P/E ratio (90.3) - may be overvalued; High P/B ratio (13.85) 5.018%

P/E ratio

90.29

Price against trailing earnings

very highWhat this means

You pay 90.29 for every 1 unit of annual earnings.

Above 40 the price assumes growth that then has to actually arrive.

Forward P/E

58.17

Price against forecast earnings

highWhat this means

Price against next year's *forecast* earnings.

Even next year's expected earnings do not bring the multiple down much.

Price to book

13.85

Price against balance-sheet equity

well above bookWhat this means

Price against the accounting value of the company's net assets.

Normal for asset-light businesses, where the value sits in brands and software the balance sheet never records.

Price to sales

20.67

Price against revenue

highWhat this means

Price against revenue — usable when a company has no profit yet.

The price assumes today's revenue will convert into much more profit later.

EV / EBITDA

57.73

Whole-company value against cash earnings

highWhat this means

Whole-company value, debt included, against cash earnings.

Expensive even before interest, tax and depreciation are considered.

Enterprise value

₹2.29 L Cr

Market value plus debt, minus cash — the price of the whole business

Shares outstanding

26,54,68,580

Shares the profit is split across

Dividend yield

0.35%

Annual dividend against price

modestWhat this means

Annual dividend as a percentage of the share price.

A small income component.

TechnicalRSI in healthy range (30-70); MACD bearish (negative histogram) 40.015%

RSI (14)

67.6

Above 70 overbought, below 30 oversold

neutralWhat this means

A 0–100 momentum gauge over the last 14 sessions.

The middle band, where most trading days sit.

MACD

321.47

Momentum against its own trend

MACD histogram

-28.93

Positive is bullish

Risk4 measured figures 65.012%

Volatility, annualised

27.04%

How far it swings in a year

normalWhat this means

How far the price typically swings over a year.

A typical range for an individual share.

Beta

0.22

Moves against the wider market

steadier than the marketWhat this means

How much the price moves relative to the wider market.

Tends to move less than the index, in both directions.

Maximum drawdown

-48.40%

Worst peak-to-trough fall

significantWhat this means

The worst peak-to-trough fall in the period measured.

A serious decline, though not unusual over a multi-year window.

Risk category

High

The engine's own banding

Analyst viewStrong analyst coverage (29 analysts) 65.010%

Consensus

Hold

What covering analysts rate it

Analysts covering

29

Mean price target

₹8,292.48

Highest target

₹11,700.00

Lowest target

₹6,000.00

Implied upside

-5.17%

Target against today's price

below the targetWhat this means

How far the mean analyst target sits above today's price.

Analysts' average target is under the current price.

Price against the NIFTY 50

180 trading days to 2026-08-25

DIVISLAB.NS is nan% down over the window, against 7.5% down for the NIFTY 50 — behind by nan points.
DIVISLAB.NS +nan%NIFTY 50 -7.5%
Show the numbers
Sampled across the window. Both columns are rebased to 100 on 2025-12-05, so they can be compared directly.
DateCloseDIVISLAB.NS rebasedNIFTY 50 rebased
2025-12-05₹6,447.92100.0100.0
2025-12-29₹6,364.2698.799.1
2026-01-19₹6,115.7894.897.7
2026-02-10₹6,150.1495.499.0
2026-03-04₹6,290.0697.693.5
2026-03-25₹5,990.8092.989.0
2026-04-21₹6,260.1997.193.9
2026-05-13₹6,768.09105.089.4
2026-06-03₹6,549.49101.689.4
2026-06-24₹6,726.77104.391.7
2026-07-15₹7,243.13112.492.0
2026-08-05₹8,388.00130.194.0

How the score was built

Each category is scored 0–100, then multiplied by its weight. The seven contributions sum to the quality score.
CategoryScoreWeightContribution
Financial health95.023%21.9
Growth & momentum55.022%12.1
Valuation5.018%0.9
Technical40.015%6.0
Risk65.012%7.8
Analyst view65.010%6.5
ESG50.00%0.0
Quality score100%55.1

ESG is scored but carries no weight in this grade. Add ?esg=1 to the address to include it — the engine then redistributes weight across the other six, so the whole scorecard changes, not just one row.

Argue with the model

Every other grader hands you a number. This one hands you the model.

Move a slider, press Recalculate, and the grade is rebuilt from the same category scores. Nothing is hidden: the scores are the engine's, only the weighting is yours.

18%
23%
22%
12%
15%
10%
0%

These are IQInvest's own weights, totalling 100%.

Your grade

F

55.1 / 100

Identical to the IQInvest grade.

All 43 metricsOne flat sortable table, for when you want everything at once.
Metric Category Value Source
Analysts coveringAnalyst view29Yahoo Finance
ConsensusAnalyst viewHoldYahoo Finance
Highest targetAnalyst view₹11,700.00Yahoo Finance
Implied upsideAnalyst view-5.17%Yahoo Finance
Lowest targetAnalyst view₹6,000.00Yahoo Finance
Mean price targetAnalyst view₹8,292.48Yahoo Finance
Debt to equityFinancial health0.04Yahoo Finance
Earnings growthFinancial health65.70%Yahoo Finance
Gross marginFinancial health61.24%Yahoo Finance
Operating marginFinancial health36.66%Yahoo Finance
Payout ratioFinancial health31.01%Yahoo Finance
Profit marginFinancial health26.05%Yahoo Finance
RevenueFinancial health₹11,230 CrYahoo Finance
Revenue growthFinancial health27.80%Yahoo Finance
Average daily returnGrowth & momentum0.06%Yahoo Finance
Best dayGrowth & momentum9.73%Yahoo Finance
Sharpe ratioGrowth & momentum0.51Yahoo Finance
Win rateGrowth & momentum50.89%Yahoo Finance
Worst dayGrowth & momentum-11.71%Yahoo Finance
52-week highMarket data₹8,744.50Yahoo Finance
52-week lowMarket data₹5,636.50Yahoo Finance
Average volumeMarket data4,31,481Yahoo Finance
Day highMarket data₹8,744.50Yahoo Finance
Day lowMarket data₹8,497.00Yahoo Finance
EmployeesMarket data11,565Yahoo Finance
OpenMarket data₹8,500.00Yahoo Finance
Previous closeMarket data₹8,496.00Yahoo Finance
VolumeMarket data5,63,721Yahoo Finance
BetaRisk0.22Yahoo Finance
Maximum drawdownRisk-48.40%Yahoo Finance
Risk categoryRiskHighYahoo Finance
Volatility, annualisedRisk27.04%Yahoo Finance
MACDTechnical321.47Yahoo Finance
MACD histogramTechnical-28.93Yahoo Finance
RSI (14)Technical67.6Yahoo Finance
Dividend yieldValuation0.35%Yahoo Finance
Enterprise valueValuation₹2.29 L CrYahoo Finance
EV / EBITDAValuation57.73Yahoo Finance
Forward P/EValuation58.17Yahoo Finance
P/E ratioValuation90.29Yahoo Finance
Price to bookValuation13.85Yahoo Finance
Price to salesValuation20.67Yahoo Finance
Shares outstandingValuation26,54,68,580Yahoo Finance
Add to portfolio Compare Peers Set a price target

Yahoo Finance via yfinance · delayed 15 minutes or more